Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
ImmuneDiscover Sweden AB
AB
Active
Org 5592383938
Stockholm
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2020
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ImmuneDiscover Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
1M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
−29
EBITDA
−123
12
−144
−194
549
Depreciation & amort.
−22
−22
−22
−22
−22
EBIT
−145
−10
−166
−216
527
Net financials
—
−4
—
1
1
Profit before tax
5
2
−7
−215
453
Tax
−3
−2
−0
−0
−50
Net profit
2
0
−7
−215
403
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
1 362
1 017
980
579
1 033
Equity
836
837
830
489
892
Long-term debt
0
0
0
0
—
Short-term debt
350
21
150
90
66
Total debt
350
21
150
90
66
Financial ratios
5-year trend
EBITDA-margin
54885500.0%
This company
15.8%
Market median
+347376482% vs market
2021
2025
Soliditetsgrad
86.4%
This company
38.2%
Market median
+126% vs market
2021
2025
Egenkapitalforrentning
45.2%
This company
18.4%
Market median
+146% vs market
2021
2025
Nettoresultatgrad
40290200.0%
This company
8.1%
Market median
+497409777% vs market
2021
2025
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Gæld/egenkapital
0.16×
This company
0.62×
Market median
+74% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on ImmuneDiscover Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
